Term sheet red-flag checklist
The terms worth stopping on, as a list to run before you sign anything.
Checklist
SAFEs and terms
Focus negotiation energy where it changes the company.
By The Raise Memo team · August 19, 2026 · Updated October 13, 2026
Short answer: Prioritize terms that change the cash the company receives, ownership after the round, proceeds in a sale, decisions requiring consent and obligations on the founders. Bring counsel the proposed documents, current cap table and a short list of company priorities. Negotiating a higher valuation alone will not resolve a restrictive consent right or an unexpected vesting reset.
Write down the amount, the milestone it funds and the date the company needs usable cash. Compare each offer against that plan. If funding arrives in stages, record the conditions for each tranche and model the company’s cash balance if a later payment is delayed. An announced round size is not necessarily the amount available at the first close.
Ask for a cap table that includes existing shares, outstanding convertibles, options and the proposed pool increase. State whether the valuation is pre-money or post-money and which securities the calculation includes. Keep the amount raised fixed when comparing prices so you can see which term causes the difference.
For illustration, a $2 million investment at an $8 million pre-money valuation gives the new investor 20% of the $10 million post-money company in a simple round with no other securities or pool changes. That arithmetic does not settle a transaction involving SAFEs or an expanded pool. Ask for the complete share calculation before relying on the percentage.
Liquidation preference, participation and conversion affect how sale proceeds are divided. Ask counsel to show the distribution at several outcomes after debts and transaction costs. The NVCA model charter presents alternative provisions; the selected language in your documents determines the result.
Then identify who can approve the next financing, a sale or a material operating decision. Board composition and investor consent are different rights. Information rights also create work: record the reports, recipients and deadlines the company would accept. Use the NVCA investors’ rights agreement as a reference for the categories, not as evidence that every investor receives every right.
Compare proposed vesting and repurchase terms with the agreements already in place. Record any credit for time served, acceleration conditions and consequences of leaving. Keep changes to the founders’ arrangements visible alongside the financing economics rather than treating them as administrative detail.
Ask which terms bind when signed, which require definitive documents and which conditions must be satisfied before closing. Track exclusivity by its actual scope and expiry. The NVCA stock purchase agreement is a useful reference for closing conditions and company representations in a US priced equity round. Different instruments and jurisdictions require their own review.
For each material question, retain the original clause, the requested change, the reason and the agreed wording. Give counsel the business consequence you are trying to address. For example, if a reporting deadline would require figures the company cannot reliably produce, say which figures are unavailable and discuss a workable cadence.
Use the term-sheet review checklist to prepare that conversation. It organizes questions; it does not review a contract or establish which terms the company should accept. If an offer does not leave enough cash or flexibility to execute the plan, include a smaller raise, another investor or a later financing in the comparison.
Related reading: liquidation preferences and questions for counsel before signing.
This is general educational information, not legal, tax, accounting, investment or financial advice. The numbers are illustrative. Have qualified counsel review the actual transaction.
Apply this to your company
Record the terms that affect ownership, proceeds and control. Bring the open questions and actual documents to your adviser.
Take it with you
The terms worth stopping on, as a list to run before you sign anything.
Checklist
Every SAFE on your cap table in one place: cap, discount, amount, and what each converts into.
Spreadsheet
Originally published in The Raise Memo.
The founder-friendly explanation of a future equity instrument.
Compare speed, control, dilution visibility, and legal complexity.
The cap is not the valuation you receive today.